ASX:RSH

Respiri (RSH) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.19 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
6.00%
Price Target
N/A

About Respiri

Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia. The company develops, produces, and sells mobile health applications. Its products include wheezo, an electronic wheeze detection tool to detect wheeze in children; respiri mobile application; and Respiri health portal. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. The company is based in Melbourne, Australia.

RSH Stock News Headlines

Move Your Money Before May 22
The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals.
Why RadioShack (RSH) Stock Skyrocketed Today
Move Your Money Before May 22
The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals.
Rush Uranium Corp. (RSH.CN)
Respiri (RSH): Initiation Objective measures for better outcomes
Respiri Limited (RSH.AX)
See More Headlines
Receive RSH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Respiri and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-6,390,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$772,196.00

Miscellaneous

Outstanding Shares
1,060,000,000
Free Float
N/A
Optionable
Not Optionable
Beta
-0.03
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Nicholas Smedley
    Executive Chairman
  • Mr. Marjan Mikel B.Sc.
    M.A.I.C.D., CEO, MD & Executive Director
  • Mr. Peter Hildebrandt
    Chief Operations Officer
  • Mr. George Vlachodimitropoulos
    Chief Technology Officer
  • Dr. Samaneh Sarraf Shirazi
    Chief Research Officer
  • Mr. Theo Antonopoulos
    Chief Commercial Officer
  • Mr. William Sigsbee
    Head of US Operations & Chief Commercial Officer
  • Mr. Justin Mouchacca B.Bus (Acc)
    C.A., CA, Joint Company Secretary
  • Ms. Nova Anne Taylor
    Joint Company Secretary
  • Prof. Noam Gavriely
    Medical & Scientific Advisor

This page (ASX:RSH) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners